Boston Baskin Cancer Groupd/b/a U. of Tennessee Cancer Inst.

Memphis, Tennessee 38104

0 studies enrolling now · 1 studies all time

What they study most

Carcinoma, Non-Small-Cell Lung

Studies at this site

• Erlotinib (Tarceva) as a Single Agent or Intercalated With Combination Chemotherapy in Patients With EGFR Positive NSCLC — Completed